To characterize the risk factors associated with neonatal thrombocytopenia among pregnant women with immune thrombocytopenic purpura (ITP). STUDY DESIGN: We reviewed the records of ITP patients who delivered during 2006-2016 at our medical center. RESULTS: Of 253 pregnancies, median maternal age at diagnosis was 29 [25][26][27][28][29][30][31][32][33] years, 222 (87.7%) had previously-diagnosed ITP and 31 (12.3%) were diagnosed with new-onset ITP during pregnancy. Baseline characteristics were comparable between the groups except for a higher proportion of nulliparity among those with new-onset disease (P¼0.002). Maternal nadir platelet count was significantly lower among those with new-onset compared to previously diagnosed ITP (median 62 X 10 9 /L vs. 81 X 10 9 /L, P¼0.005). Neonatal thrombocytopenia (<150 X 10 9 /L) was encountered in 24 (9.5%) pregnancies, and required treatment in 12 (50%) of them. Neonatal platelet count was directly correlated with maternal platelet count at delivery (r¼0.23, P¼0.01), with significantly lower maternal platelet count among those whose newborns experienced thrombocytopenia (P<0.001). Neonatal thrombocytopenia followed a higher proportion of pregnancies of women with new-onset than previously diagnosed ITP (22.6% vs. 7.7%, P¼0.02). In multivariate analysis, the presence of new-onset ITP (odds ratio [95% CI]: 4.88 (1.68, 14.16), P¼0.004) was the only independent predictor of the development of neonatal thrombocytopenia. CONCLUSION: Neonatal thrombocytopenia presented following almost one-tenth of pregnancies with ITP. New pregnancy-onset disease was the only prognostic marker for neonatal thrombocytopenia. This finding could contribute to risk stratification and individualized patient management.
824 Maternal congenital heart defects and long-term cardiovascular morbidity of the offspring 1 Soroka University Medical Center, Ben-Gurion University of the Negev, Be'er Sheva, Negev, Israel, 2 Soroka University Medical Center, Ben-Gurion University of the Negev, Negev, Israel, 3 Ben-Gurion University, Department of Epidemiology and Health Services Evaluation, Beer-Sheva, Negev, Israel OBJECTIVE: Due to advances in medical care available for patients with congenital heart disease (CHD), these patients now have a longer life span. As a result, the number of pregnancies of mothers with CHD has increased. The purpose of the current study was to examine a possible association between being born to a mother with CHD and long-term cardiovascular morbidity of the offspring. STUDY DESIGN: A population-based cohort analysis was performed including all singleton deliveries occurring between years 1991-2014 at a single tertiary medical center.The primary exposure was defined as being born to a mother with CHD. Offspring of mothers without CHD comprised the comparison (unexposed) group. The main outcome evaluated was cardiovascular morbidity of the offspring up to the age of 18 years. A Kaplan-Meier survival curve was used to compare cumulative cardiovascular morbidity incidence. A Cox proportional hazards model was conducted to control for confounders. RESULTS: During the study period 242,342 deliveries met the inclusion criteria, of which 0.2% (n¼ 368) were of mothers who had CHD. Long-term cardiovascular morbidity was comparable between offspring to women with and without CHD (1.1% vs. 0.6%, respectively, p¼0.298; Table) . However, offspring of mothers with CHD had higher rates of hypertensive disorders during childhood (0.5% vs. 0.1%; p¼0.021). The Kaplan-Meier survival curve did not demonstrate a significantly higher cumulative incidence of cardiovascular morbidity in offspring of women with CHD ( Figure, log rank p¼0.251). In the Cox regression model, while controlling for confounders such as maternal age, preterm birth, gestational diabetes mellitus and hypertensive disorders of pregnancy, delivery of a neonate to mother with CHD was not found to be independently associated with long-term cardiovascular morbidity of the offspring. CONCLUSION: Offspring of women who have congenital heart disease are not at an increased risk for long-term cardiovascular morbidity. OBJECTIVE: Women with liver transplant may be at increased risk for maternal complications, but outcomes are not well characterized. The objective of this study was to characterize maternal risk for women with liver transplants. STUDY DESIGN: This retrospective cross sectional study utilized the Nationwide Inpatient Sample from the Healthcare Cost and Utilization Project from 1998 to 2014. Women age 15 to 54 admitted for a delivery hospitalization were included and categorized on the basis of having had a liver transplantation. Trends in risk for (i) severe maternal morbidity (SMM) based on CDC criteria, (ii) liver rejection, and (ii) coagulopathy were analyzed. Given that transfusion is Poster Session IV ajog.org the most common diagnosis in the CDC SMM composite but least likely to result in significant sequelae, SMM was evaluated excluding transfusion. Log-linear regression models including demographics, hospital factors, and comorbid risk were used to analyze risk for SMM during delivery hospitalizations with adjusted risk ratios (aRR) with 95% confidence intervals (CI) as the measure of effect. Cochran-Armitage test for trend was used to assess temporal trends. The chi square and Fisher's exact tests were otherwise used for categorical comparisons. RESULTS: Of 13,695,129 deliveries, 245 were to women who had a diagnosis of a prior liver transplant. The number of women delivering with a liver transplant rose significantly from 1.0 to 2.8 per 100,000 from 1998-2000 to 2012-2014 (Figure) (p<0.01). Women with liver transplant were at higher risk of coagulopathy (3.3% vs. 0.3%, p<0.01) and severe maternal morbidity (8.2% versus 0.5%, p<0.01). 4.3% of women experienced liver rejection. Trends in severe maternal morbidity, coagulopathy, and liver rejection risk were not significant (p¼0.36, p¼0.47, p¼0.13 respectively). In the adjusted analysis, liver transplant retained significance as a risk factor associated with SMM (aRR 8.49, 95% CI 5.59-12.87). CONCLUSION: Deliveries occurring to women with liver transplants are rare, but increasing. Given risk for SMM, liver rejection, and other complications, women with liver transplants may benefit from delivering at centers with high-risk obstetricians and appropriate medical specialists.
Delivery outcomes for women with liver transplants

Inpatient psychiatric admissions and obstetric outcomes
Anna Whelan, Seema Ghelani, Elizabeth Majewski, Melissa Wagner-Schuman, Sondra Summers, Quetzal Class University of Illinois at Chicago, Chicago, IL OBJECTIVE: To examine if women who received inpatient psychiatric care during pregnancy experience increased rates of adverse obstetric outcomes including preterm birth and growth restriction. STUDY DESIGN: This is a retrospective, observational study of women who delivered at the University of Illinois Health and Hospital System (UIHHS) between January 1, 2006 and December 31, 2016. Patients were identified using ICD-9/10 code for delivery and then further separated based on codes for psychiatric diagnosis and admission to the psychiatric ward. Of women who delivered at UIHHS, 148 (0.74%) were admitted to the psychiatric ward during pregnancy. Data regarding demographics, medical and psychiatric history and obstetric outcomes were obtained and compared to information collected from 300 women with psychiatric diagnoses but without antepartum psychiatric admission, and from 300 women without psychiatric diagnoses. RESULTS: Women with psychiatric histories and antepartum inpatient psychiatric care were older than women without psychiatric histories, 27.47 AE6.4 versus 25.81 AE5.8 years old respectively, (p<0.001), but they did not differ on other demographic factors. Women with a history of psychiatric diagnosis and any type of antepartum psychiatric care (whether inpatient or outpatient) had shorter gestational lengths than those without psychiatric diagnosis 37.0 AE4.1 weeks versus 37.6 AE4.8 weeks (p<0.05). Women with psychiatric diagnoses and any type of antepartum psychiatric care also had infants with lower birthweights than those without psychiatric diagnosis, 2889.9g versus 3088.3g (p<0.01). However, women who received inpatient psychiatric care did not differ significantly in terms of gestational age at birth or birthweight when compared with either control group. CONCLUSION: Inpatient psychiatric care during pregnancy was not associated with adverse obstetric outcomes. In concordance with prior studies, women who carried a psychiatric diagnosis during pregnancy gave birth to lower birthweight babies earlier in gestation as compared with women without psychiatric histories. Although women who require inpatient psychiatric admission during pregnancy may have more severe illnesses, the care they receive may help to decrease the risks of preterm birth and low birth weight associated with psychiatric illness. OBJECTIVE: Our group has previously reported an association between adverse perinatal outcomes and the presence of abnormal cardiac remodeling caused by chronic hypertension. We sought to determine whether maternal interventricular septum thickness at end diastole (IVSd) was an independent risk factor for adverse perinatal outcomes. STUDY DESIGN: This was an analysis of interventricular septum thickness at end diastole in women with treated chronic hypertension delivered from January 2009 to January 2016. Those with an IVSd of <1 cm were compared to those !1 cm. Perinatal outcomes were assessed between the two groups.
